Table 3 Prognostic endpoints by pretest probability groups.
| Pretest risk group | n | Events | ACD | Events | CDMI | ||
|---|---|---|---|---|---|---|---|
| % (CI) | % Annualised | % (CI) | % Annualised | ||||
| Exercise | |||||||
| Low | 2372 | 19 | 0.8 (0.5 to 1.3) | 0.2 | 15 | 0.6 (0.4 to 1.0) | 0.1 |
| Intermediate | 2187 | 90 | 4.1 (3.3 to 5.1) | 1.0 | 44 | 2.0 (1.4 to 2.7) | 0.5 |
| High | 339 | 26 | 7.7 (5.2 to 11.2) | 1.8 | 12 | 3.5 (1.9 to 6.3) | 0.8 |
| Pharmacological | |||||||
| Low | 466 | 20 | 4.3 (2.7 to 6.7) | 1.0 | 8 | 1.7 (0.8 to 3.5) | 0.4 |
| Intermediate | 1129 | 150 | 13.3 (11.3 to 15.4) | 3.1 | 65 | 5.8 (4.5 to 7.3) | 1.4 |
| High | 519 | 82 | 15.8 (12.8 to 19.3) | 3.7 | 38 | 7.3 (5.3 to 10) | 1.7 |
ACD, all‐cause death; CDMI, cardiac death or myocardial infarction; CI, confidence interval.